Healthcare Real Estate Resilience: Opportunities in Life Sciences & MOB

By RadCRE Research · 2026-10-11 · Market Updates

Healthcare real estate demonstrates remarkable resilience, driven by increasing demand for services and favorable economic trends, with sectors like Medical Office assets leading market performance [2, 4].

Healthcare Real Estate Shows Resilience Amidst Market Shifts

The healthcare real estate sector, encompassing both life sciences facilities and medical office buildings (MOBs), continues to exhibit significant stability and long-term investment potential, largely driven by consistent demand for healthcare services [4]. This resilience positions these asset classes favorably in a dynamic commercial real estate landscape.

Key Market Drivers and Performance

Investment activity across various commercial real estate sectors has seen shifts, with Retail, Multifamily, Industrial, and Medical Office assets leading market performance due to favorable economic and demographic trends [2]. The ongoing demand for healthcare services ensures a consistent need for associated real estate, including hospitals, outpatient centers, and rehabilitation centers, as populations grow and age [4]. This foundational demand underpins the sector's stability, making it a prime investment avenue [4]. Property owners are encouraged to evaluate their portfolios and consider diversifying into healthcare properties [4].

While specific new speculative office development is not anticipated in the near term for some markets, like the Rhode Island office market, the adaptive reuse of older historic office buildings and user demand contribute to overall market stability [2]. For instance, a notable transaction in Q1 involved FM's acquisition of 10 Memorial Blvd for $68.5 million, which not only represented a significant user purchase but also removed nearly 60,000 square feet of Class A product from the market, further constraining supply [2]. This highlights the potential for existing assets, including those that could be repurposed for healthcare or life sciences use, to command value.

Life Sciences Outlook and Economic Context

The broader U.S. life sciences sector is projected to experience a recovery in its real estate market, as outlined in CBRE's "2026 U.S. Life Sciences Trends" report [1]. This recovery is influenced by evolving workforces and fundamental drivers specific to the life sciences industry. The stability of the healthcare real estate market, which includes life sciences, presents unique opportunities for property owners, investors, and business owners to strategically manage and expand their portfolios [4].

Economically, sales volume in some markets remains tepid, with interest rates experiencing sharp increases at the end of Q2 due to global conflicts [2]. Expectations are that future Federal Funds rate reductions may stay flat or even increase over the next six to twelve months [2]. Despite these broader economic pressures, the consistent demand inherent in healthcare and life sciences provides a buffer against volatility, attracting investors seeking long-term stability [4].

Geographic Considerations and Investor Strategy

While reports highlight a strong outlook for healthcare real estate nationally, regional variations exist. For example, specific markets like Orange County, California, are recognized as dynamic commercial real estate markets [5]. Investors need to analyze the demand for specific healthcare facilities within various markets and stay informed about market trends to identify new investment opportunities [4]. Lenders are also adapting their strategies to align with the evolving healthcare real estate market, reflecting the sector's unique characteristics and growth trajectory [4].

RadCRE Perspective

"The consistent, non-discretionary demand for healthcare services provides an undeniable tailwind for both Medical Office Buildings and Life Sciences real estate. Even with broader economic headwinds, such as the sharp interest rate increases observed in Q2 2026 and the prospect of flat or rising Federal Funds rates, these sectors offer a defensive play with robust long-term fundamentals. The reported 'recovery' in U.S. life sciences and the ongoing stability of healthcare properties underscore their value as strategic portfolio diversifiers. We advise clients to closely scrutinize market-specific demand for specialized facilities, as this will dictate success in an increasingly competitive landscape, particularly given the limited new speculative development in certain areas." – Majid Radaei, Founder & Principal Broker, RadCRE

Tags: Healthcare Real Estate, Medical Office Buildings, Life Sciences Real Estate, CRE Investment, Market Trends